VJHemOnc is committed to improving our service to you

EBMT 2020 | Duvelisib in CAR T-cell therapy for CLL

VJHemOnc is committed to improving our service to you

Edmund Waller

Edmund Waller, MD, PhD, FACP, Division of Hematology/Oncology, Emory Clinic, Atlanta, GA, outlines the use and activity of duvelisib in CAR T-cell therapy for patients with chronic lymphocytic leukemia (CLL). This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter